Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cytosorbents Corp (CTSO)
NASDAQ:CTSO
Cytosorbents (CTSO) Stock Forecast & Price Target
457 Followers
See the Price Targets and Ratings of:
CTSO Analyst Ratings
Hold
0 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CTSO Stock 12 Month Forecast
Average Price Target
$1.00
▼(-4.76% Downside)
| Highest Price Target$1.00 | Average Price Target$1.00 | Lowest Price Target$1.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
H.C. Wainwright
Reiterated
05/10/24
EF Hutton
$10→$4
Buy
$4.00
(280.95% Upside)
Reiterated
12/28/23
CytoSorbents (CTSO) PT Lowered to $4 at Dawson JamesDawson James analyst Jason Kolbert lowered the price target on CytoSorbents (NASDAQ: CTSO) to $4.00 (from $10.00) while maintaining a Buy rating.
B.Riley Financial
$4
Buy
$4.00
(280.95% Upside)
Reiterated
10/17/23
In advance of the upcoming data readout of the Ph. III STAR-T trial in 4Q23, we reiterate our Buy rating on and review DrugSorb’s MOA and clinical data accumulated up to date. Through our analysis, we view this data readout as a highly asymmetric catalyst that favors upward stock movement. We believe DrugSorb addresses the unmet need to reverse the effect of blood thinner Brilinta before patients safely go into surgeries and unlock a potential >$200M TAM. The STAR-T trial was completed in August 2023, with top-line data anticipated by YE23 supporting a regulatory submission in 2024(E), followed by a commercial launch in 2025(E).
Best Analysts Covering Cytosorbents
Which Analyst Should I Follow If I Want to Buy CTSO and Sell After:
1 Month
xxx
Success Rate
9/29 ratings generated profit
Average Return
-2.00%
reiterated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 31.03% of your transactions generating a profit, with an average return of -2.00% per trade.
3 Months
xxx
Success Rate
14/29 ratings generated profit
Average Return
+11.09%
reiterated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 48.28% of your transactions generating a profit, with an average return of +11.09% per trade.
1 Year
Success Rate
14/29 ratings generated profit
Average Return
+9.50%
reiterated a buy rating 7 months ago
Copying Jason Kolbert's trades and holding each position for 1 Year would result in 48.28% of your transactions generating a profit, with an average return of +9.50% per trade.
2 Years
xxx
Success Rate
3/29 ratings generated profit
Average Return
-43.60%
reiterated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 10.34% of your transactions generating a profit, with an average return of -43.60% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CTSO Analyst Recommendation Trends
Rating
Nov 23
Dec 23
Jan 24
Mar 24
May 24
Strong Buy
4
4
3
1
0
Buy
0
0
0
0
0
Hold
0
1
2
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
5
5
4
3
Each month's total comprises the sum of three months' worth of ratings.
CTSO Financial Forecast
CTSO Stock Forecast FAQ
What is CTSO’s average 12-month price target, according to analysts?
Based on analyst ratings, Cytosorbents Corp’s 12-month average price target is $1.00.
What is CTSO’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CTSO, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CTSO a Buy, Sell or Hold?
Cytosorbents Corp has a consensus rating of Hold which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
What is Cytosorbents Corp’s price target?
The average price target for Cytosorbents Corp is $1.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $1.00 ,the lowest forecast is $1.00. The average price target represents -4.76% Decrease from the current price of $1.05.
The highest analyst price target is $1.00 ,the lowest forecast is $1.00. The average price target represents -4.76% Decrease from the current price of $1.05.
What do analysts say about Cytosorbents Corp?
Cytosorbents Corp’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of CTSO?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.